Poland's Selvita expands US operations with West Coast office

Poland-based biotech firm Selvita, the largest drug discovery company in Central and Eastern Europe, has just opened its West Coast US office, located in San Bruno, California.

Selvita initiated its US operations in September 2015, opening a fully-owned US subsidiary, Selvita Inc, headquartered in Cambridge, Massachusetts. Now the company is officially opening its second office, which is dedicated to the support of the ongoing and future projects for business partners from the West Coast of USA. Last year it also launched a subsidiary in the UK (The Pharma Letter May 5, 2015).

“The US drug discovery market is absolutely strategic for Selvita. It is not only where most of our revenue comes from, but also where we put most of our hopes in,” said Pawel Przewiezlikowski, chief executive of Selvita, adding: “We are continuously investing in top class-facilities and best professionals. In 2016 we are opening our second research facility in Poznan, Poland, and we believe we have even more to offer to our customers.”